Prochetto, E. S., Roldán, C., Bontempi, I., Bertona, D., Peverengo, L. M., Vicco, M. H., . . . Cabrera, G. (2017). Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/ suppressor phenotype. Web
Citación estilo ChicagoProchetto, Estefanía Soledad, et al. Trans-sialidase-based Vaccine Candidate Protects against Trypanosoma Cruzi Infection, Not Only Inducing an Effector Immune Response but Also Affecting Cells With Regulatory/ Suppressor Phenotype. 2017.
Cita MLAProchetto, Estefanía Soledad, et al. Trans-sialidase-based Vaccine Candidate Protects against Trypanosoma Cruzi Infection, Not Only Inducing an Effector Immune Response but Also Affecting Cells With Regulatory/ Suppressor Phenotype. 2017.